IDVZ - ETF AI Analysis

Compare

Top Page

Opal International Dividend Income ETF (IDVZ)

Rating:60Neutral

Price Target:

$32.00

The Opal International Dividend Income ETF (IDVZ) has a balanced overall rating, reflecting a mix of strong and weaker holdings. Top contributors like TSMC, with its focus on advanced technologies and AI, and GSK, with its robust growth in specialty medicines and solid dividend yield, provide significant strength to the fund. However, weaker performers such as British American Tobacco, which faces profitability challenges and bearish technical indicators, slightly weigh down the overall rating. A key risk factor for the ETF is its exposure to companies with high leverage or valuation concerns, which could impact performance in volatile market conditions.

Positive Factors

Strong Top Holdings

Several key positions, such as Alibaba and Orange SA, have delivered strong year-to-date gains, supporting the ETF's overall performance.

Sector Diversification

The ETF spreads investments across multiple sectors, including Consumer Defensive, Financial, and Health Care, reducing reliance on any single industry.

Steady Performance

The fund has shown consistent positive returns year-to-date and over the past three months, indicating solid momentum.

Negative Factors

High Geographic Concentration

With over 87% of its exposure in U.S. companies, the ETF is heavily reliant on the U.S. market and lacks global diversification.

Underperforming Holding

Novo Nordisk, one of the top holdings, has lagged with negative year-to-date performance, potentially dragging on overall returns.

Higher Expense Ratio

The ETF charges a relatively high expense ratio of 0.75%, which may eat into investor returns compared to lower-cost alternatives.

IDVZ vs. SPDR S&P 500 ETF (SPY)

AUM113.60M

RegionGlobal Ex-U.S.

Expense Ratio0.75%

Beta0.44

IssuerOPAL

Inception DateDec 26, 2024

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume12,913

30 Day Avg. Volume14,228

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IDVZ Summary

The Opal International Dividend Income ETF (IDVZ) is designed for investors who want steady income from high-dividend-paying companies worldwide. It includes well-known companies like TSMC and Novo Nordisk, and focuses on industries such as consumer defensive and financials. This ETF is a good option for those looking to diversify their portfolio while earning consistent dividends from international markets. However, new investors should be aware that its performance can fluctuate with global market conditions, and it has significant exposure to U.S. companies despite being international-focused.

How much will it cost me?The Opal International Dividend Income ETF (IDVZ) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on high dividend yield opportunities across global markets, requiring more research and management effort.

What would affect this ETF?The Opal International Dividend Income ETF (IDVZ) could benefit from global economic growth and increased demand for dividend-paying stocks, especially in sectors like Consumer Defensive and Financials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can make dividend-focused investments less attractive, and potential regulatory changes or geopolitical tensions in its international markets. Its exposure to diverse sectors and regions helps mitigate risks but does not eliminate them entirely.

IDVZ Top 10 Holdings

The Opal International Dividend Income ETF (IDVZ) leans heavily on Consumer Defensive and Financial sectors, with notable contributions from global dividend stalwarts like GSK and British American Tobacco. GSK is rising steadily, buoyed by strong specialty medicine growth, while British American Tobacco’s high dividend yield supports the fund despite mixed profitability trends. On the flip side, telecom names like Orange SA and Royal KPN are lagging, dragging on performance with bearish momentum. With its global ex-U.S. focus, IDVZ offers a diverse income stream but faces headwinds from weaker telecom stocks in its portfolio.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
GSK	GlaxoSmithKline	3.99%	$4.52M	$94.97B	37.60%	77 Outperform
ORANY	Orange SA	3.99%	$4.52M	$42.69B	51.46%	63 Neutral
RBGLY	Reckitt Benckiser Group	3.85%	$4.36M	$51.63B	25.44%	78 Outperform
ENLAY	Enel SpA Unsponsored ADR	3.81%	$4.32M	$103.73B	44.46%	66 Neutral
KKPNY	Royal KPN	3.28%	$3.72M	$17.64B	17.32%	68 Neutral
BTI	British American Tobacco	3.20%	$3.63M	$119.64B	46.74%	59 Neutral
WMMVY	Wal-Mart de Mexico	3.14%	$3.56M	$57.81B	26.68%	75 Outperform
PBR	Petroleo Brasileiro SA- Petrobras	3.12%	$3.54M	$79.57B	-13.79%	77 Outperform
IMBBY	Imperial Brands	3.03%	$3.43M	$33.07B	28.53%	68 Neutral
TSM	TSMC	2.94%	$3.34M	$1.13T	53.79%	81 Outperform

IDVZ Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

30.62

Negative

100DMA

29.97

Positive

200DMA

28.64

Positive

Market Momentum

MACD

<0.01

Positive

RSI

45.10

Neutral

STOCH

7.53

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDVZ, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 30.71, equal to the 50-day MA of 30.62, and equal to the 200-day MA of 28.64, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.10 is Neutral, neither overbought nor oversold. The STOCH value of 7.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IDVZ.

IDVZ Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IDVZ	―	―	$113.60M	0.75%	60 Neutral
FDV	―	―	$502.84M	0.50%	71 Outperform
TBG	―	―	$191.49M	0.59%	68 Neutral
ELCV	―	―	$148.76M	0.49%	69 Neutral
HIDV	―	―	$133.54M	0.35%	71 Outperform
FDIV	―	―	$61.96M	0.35%	68 Neutral

Performance Comparison

IDVZ

Opal International Dividend Income ETF

30.44

6.42

26.73%

FDV

Federated Hermes U.S. Strategic Dividend ETF

―

TBG

TBG Dividend Focus ETF

―

ELCV

Eventide High Dividend ETF

―

HIDV

AB US High Dividend ETF

―

FDIV

MarketDesk Focused U.S. Dividend ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents